SCHEMBL195995

SCHEMBL195995

CC(c1c[nH]c2ccccc12)C(N)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 3/20 0.53
FFAR1 O14842 2/20 0.53
HTR2A P28223 2/20 0.53
HTR2C P28335 2/20 0.53
HTR2B P41595 2/20 0.53
KMT2A Q03164 5/20 0.51
MEN1 O00255 4/20 0.51
MAPT P10636 3/20 0.51
KDM4E B2RXH2 2/20 0.51
APAF1 O14727 1/20 0.51
POLB P06746 1/20 0.51
RECQL P46063 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
LMNA P02545 1/20 0.51
MPO P05164 1/20 0.51
TSHR P16473 1/20 0.51
BLM P54132 1/20 0.51
PMP22 Q01453 1/20 0.51
HIF1A Q16665 1/20 0.51
PKM P14618 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31646404 1.00 GPR84 (0.53) GPR84FFAR1HTR2AHTR2CHTR2B
SCHEMBL31646035 1.00 GPR84 (0.53) GPR84FFAR1HTR2AHTR2CHTR2B
SCHEMBL31000529 1.00 GPR84 (0.53) GPR84FFAR1HTR2AHTR2CHTR2B
SCHEMBL6588456 1.00 GPR84 (0.53) GPR84FFAR1HTR2AHTR2CHTR2B
SCHEMBL18135252 1.00 GPR84 (0.53) GPR84FFAR1HTR2AHTR2CHTR2B
SCHEMBL31646630 1.00 GPR84 (0.53) GPR84FFAR1HTR2AHTR2CHTR2B
SCHEMBL31646396 1.00 GPR84 (0.53) GPR84FFAR1HTR2AHTR2CHTR2B
SCHEMBL5913085 1.00 GPR84 (0.53) GPR84FFAR1HTR2AHTR2CHTR2B
SCHEMBL195996 1.00 GPR84 (0.53) GPR84FFAR1HTR2AHTR2CHTR2B
SCHEMBL5913301 1.00 GPR84 (0.53) GPR84FFAR1HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 473 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250204528-A1 USE OF 2-AMINO-3-INDOLYL BUTYRIC ACID OR 3-METHYLPYRROLIDINE-2-CARBOXYLIC ACID AS PLANT IMMUNITY ELICITOR NANJING TIANNONG BIOTECHNOLOGY CO., LTD (CN) 2025-06-26 US claimed
US-11879143-B2 Engineered beta-subunit of tryptophan synthase for production of non-canonical amino acids CALIFORNIA INSTITUTE OF TECHNOLOGY (US) 2024-01-23 US claimed
CN-115486457-B Application of 2-amino-3-indolyl butyric acid as plant immunity inducer 南京天秾生物技术有限公司 2024-01-02 CN claimed
WO-2023155855-A1 APPLICATION OF 2-AMINO-3-INDOLE BUTYRIC ACID IN PROMOTING PLANT GROWTH 南京天秾生物技术有限公司 2023-08-24 WO claimed
WO-2023103931-A1 APPLICATION OF 2-AMINO-3-INDOLYL BUTYRIC ACID OR 3-METHYLPYRROLIDINE-2-CARBOXYLIC ACID AS PLANT IMMUNE RESISTANCE INDUCER 南京天秾生物技术有限公司 2023-06-15 WO claimed
CN-114503989-B Application of 2-amino-3-indolyl butyric acid in promoting plant growth 南京天秾生物技术有限公司 2023-05-26 CN claimed
CN-115486457-A Application of 2-amino-3-indolyl butyric acid as plant immunity inducer 南京天秾生物技术有限公司 2022-12-20 CN claimed
CN-114128716-B Application of 2-amino-3-indolebutyric acid or 3-methylpyrrolidine-2-carboxylic acid as plant immunity inducer 南京天秾生物技术有限公司 2022-09-06 CN claimed
CN-114503989-A Application of 2-amino-3-indolyl butyric acid in promoting plant growth 南京天秾生物技术有限公司 2022-05-17 CN claimed
CN-114128716-A Application of 2-amino-3-indolebutyric acid or 3-methylpyrrolidine-2-carboxylic acid as plant immunity inducer 南京天秾生物技术有限公司 2022-03-04 CN claimed
US-20160298152-A1 ENGINEERED BETA-SUBUNIT OF TRYPTOPHAN SYNTHASE FOR PRODUCTION OF NON-CANONICAL AMINO ACIDS THE CALIFORNIA INSTITUTE OF TECHNOLOGY 2016-10-13 US claimed
CN-101298472-A Growth inhibition hormone peptide derivatives and preparation thereof GUOXIA HAN (CN) 2008-11-05 CN claimed
US-5658885-A OLIGOPEPTIDES; ANTICOAGULANTS; ENZYME INHIBITORS; THROMBIN THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) 1997-08-19 US claimed
CN-121730291-A Application of 2-amino-3-indolyl butyric acid as plant phytotoxicity relieving agent 南京农业大学 2026-03-27 CN disclosed
CN-121730291-A Application of 2-amino-3-indolyl butyric acid as plant phytotoxicity relieving agent 南京农业大学 2026-03-27 CN disclosed
US-20250204528-A1 USE OF 2-AMINO-3-INDOLYL BUTYRIC ACID OR 3-METHYLPYRROLIDINE-2-CARBOXYLIC ACID AS PLANT IMMUNITY ELICITOR NANJING TIANNONG BIOTECHNOLOGY CO., LTD (CN) 2025-06-26 US disclosed
US-5278191-A Nervous system disorders G. D. SEARLE & CO. (US) 1994-01-11 US disclosed
EP-0547178-A1 NOVEL CHOLECYSTOKININ ANTAGONISTS, THEIR PREPARATION AND THERAPEUTIC USE WARNER-LAMBERT COMPANY (US) 1993-06-23 EP disclosed
US-5141960-A Central nervous system disorders G. D. SEARLE & CO. (US) 1992-08-25 US disclosed
WO-1992004045-A1 NOVEL CHOLECYSTOKININ ANTAGONISTS, THEIR PREPARATION AND THERAPEUTIC USE WARNER-LAMBERT COMPANY (US) 1992-03-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250204528-A1 USE OF 2-AMINO-3-INDOLYL BUTYRIC ACID OR 3-METHYLPYRROLIDINE-2-CARBOXYLIC ACID AS PLANT IMMUNITY ELICITOR IDO2, AMPD2, BCAT2 GPR84 1560/4885FFAR1 726/4885HTR2A 1113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.